The Accessory Protein ORF3a Hijacks CLCC1 Chloride Channel to Cause ER Dysfunction in Beta-coronavirus Pathogenesis

分享:

简介:

  • 作者: liang guo, Baoying Huang, Hanzhi Yu, Yi Xu, Lei Wei, Jijie zheng, yuanzhe li, Di Wu, Peng Zhao, Changcheng Wu, Wenjie Tan, Yichang Jia
  • 杂志: Research Square
  • 出版日期: 2024 Dec 16

论文中使用的产品/服务

询价

摘要

The endoplasmic reticulum (ER) homeostasis is crucial for host cells and is influenced by beta-coronaviruses upon invasion. However, the mechanisms by which viral proteins interact with ER-resident host factors to modulate ER functions and morphology remain poorly understood. The accessory protein ORF3a of SARS-CoV-2 plays a pivotal role in viral pathogenesis and modulating host immune responses. The ER-localized chloride channel CLCC1 has been identified as a strong interaction partner of ORF3a, yet the consequences of this interaction are not fully elucidated. Here, we demonstrate that ORF3a interacts with CLCC1 to modulate ER ion homeostasis, including increased ER luminal [Cl?], [K+], and decreased ER [Ca2+], and to trigger unfolded protein responses. The ORF3a-CLCC1 interaction is linked to ER phagy and nucleophagy, monitored by newly developed ratiometric reporters. Mechanistically, ORF3a induces the formation of endogenous CLCC1 puncta, while overexpression of CLCC1 attenuates ORF3a-associated toxicity by sequestering ORF3a within the ER. Furthermore, the conservation of ORF3a functions across beta-coronaviruses suggests it is a potential therapeutic target and uncovers ORF3a-mediated phenotypes spatiotemporally. In addition, ORF3a expression in mouse brains causes ER stress, ER phagy, nucleophagy, and endomembrane reorganization, shedding light on the neurological manifestations and long-term effects observed in COVID-19 patients.

关于派真

作为一家专注于AAV 技术十余年,深耕基因治疗领域的CRO&CDMO,派真生物可提供从载体设计、构建到 AAV、慢病毒和 mRNA 服务的一站式解决方案。凭借深厚的技术实力、卓越的运营管理和高标准的服务交付,我们为全球客户提供一站式CMC解决方案,包括从早期概念验证、成药性评估到IITINDBLA的各个阶段。

 

凭借我们独立知识产权的π-alphaTM 293 细胞AAV高产技术平台,我们能将AAV产量提高多至10倍,每批次产量可达1×10¹⁷vg,以满足多样化的商业化和临床项目需求。此外,我们定制化的mRNA和脂质纳米颗粒(LNP)产品及服务覆盖药物和疫苗开发的各个阶段,从研发到符合GMP的生产,提供端到端的一站式解决方案。

下载

用户登录

还没账号? 请注册
手机验证码登录
账号密码登录
手机号码*
验证码*
忘记密码?

首次使用手机号登录将自动为您注册

登录即代表阅读并接受《注册协议》 《用户协议》

新用户注册

已有账号?
手机注册
邮箱注册
手机号码*
验证码*
机构名称*
客户类型*

重置密码

手机找回密码
邮箱找回密码
手机号码*
验证码*
设置新密码*
确认新密码*